Skip to main content
. 2024 Feb 29;13(5):430. doi: 10.3390/cells13050430

Figure 3.

Figure 3

Proposal for the identification of novel next-generation biomarkers in GCA that possess two characteristics: (i) they are tightly related to the underlying pathogenetic mechanism; and (ii) they are the outcome of integrative analysis of high-throughput assays during disease activity and inactivity. They may also be potentially used as activity indices, organ damage markers, and treatment selection tools.